β-Glucuronidase-IN-1

Research use only, not for human use.

β-Glucuronidase-IN-1 is an E. coli β-glucuronidase (β-glucuronidase) inhibitor with a potent, selective, non-competitive, and orally active IC50 and Ki value of 283 nM and 164 nM, respectively, against E. coli β-glucuronidase.

β-Glucuronidase-IN-1 is a potent, selective, uncompetitive, and orally active E. coli bacterial β-glucuronidase inhibitor, exhibitingan IC50 and a Ki of 283 nM and 164 nM, respectively.

β-Glucuronidase-IN-1 (Inhibitor 1) (0.01-100 μM) inhibits E. coli?β-glucuronidase activity as a dose-dependent manner and exhibits an IC50 and a Ki value with 283 nM and 164 nM, respectively.β-Glucuronidase-IN-1 (100 μM; 24-72 hours) maintains potent efficacy in living bacterial cells (EC50=17.7 nM), it does not affect bacterial cell growth under aerobic or anaerobic conditions or killing mammalian epithelial cells. Cell Viability AssayCell Line:CMT93, CaCO-2, HCT116 cells Concentration:100 μM Incubation Time:24hours, 48 hours and 72 hours Result:Did not impact mammalian cell survival and any reduction in cell viability were attributed to the presence of DMSO.

β-Glucuronidase-IN-1 (oral gavage; 10 μg; twice per day; 11 days) protects the mouse GI epithelium from CPT-11–induced damage and protects the glandular structure of CPT-11-treated intestinal tissues.Animal Model:Healthy 6- to 8-week-old Balb/cJ mice Dosage:10 μg Administration:Oral gavage; twice per day; 11 daysResult:Alleviated CPT-11-induced toxicity in mice.

——

GPCR/G Protein

Antibacterial

Antibacterial

——

——

484006-66-8

425.54

C23H27N3O3S

>98% (HPLC)

In Vitro:?DMSO : 100 mg/mL (235.00 mM; Ultrasonic (<60°C)

CCOc1ccc(NC(=S)N(CCO)Cc2cc3cc(C)cc(C)c3[nH]c2=O)cc1

——

(-20℃)

With Ice Pack

≥ 2 years